Health Services Research
Latest posts by Health Services Research (see all)
- Total Cost of Care Lower among Medicare Fee-for-Service Beneficiaries Receiving Care from… - Jul. 31, 2014
- Observation Services and Observation Care—One Word Can Mean a World of Difference - Jul. 24, 2014
- Higher Medicare SNF Care Utilization by Dual-Eligible Beneficiaries: Can Medicaid Long-Term… - Jul. 22, 2014
- Factors Affecting Receipt of Expensive Cancer Treatments and Mortality: Evidence from Stem Cell… - Jul. 22, 2014
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: